 Conference Call Scheduled for Tuesday, November 15 at 11:30 AM EST NORTHVALE, NJ ACCESSWIRE November 15, 2022 Elite Pharmaceuticals, Inc. Elite or the CompanyOTCQB:ELTP, a specialty pharmaceutical company developing niche generic products, announced results for the second quarter of fiscal year 2023 ended September 30, 2022 Second Quarter. Consolidated revenues for the six-month period ended September 30, 2022, were 16.3 million, an increase of 0.64 million or 4 as compared to the comparable period of the prior fiscal year. 